Liquidia Statistics
NASDAQ: LQDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
28.74+2.06 (+7.70%)
Market open · Delayed 15 min · as of Oct 8, 10:45 AM ET
Liquidia by the numbers
Liquidia has a market capitalization of $2.57 billion based on 89.51M shares outstanding. Its trailing P/E ratio is 20.7, and its forward P/E is 12.0. The stock trades 58.0% below its 50-day average and 46.9% below its 200-day average.
Average daily trading volume is 2.40M shares, or about $68.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LQDA valuation vs. peer median
| Metric | LQDA | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.57B | $2.34B | +10% |
| Forward P/E | 12.0 | 7.6 | +58% |
| Avg. volume | 2.40M | 827.53K | +190% |
Peer median across 8 companies: HCM, SUPN, BHC, NAMS, HRMY, MBX, NRIX, IRON.
Valuation
- Market cap
- $2.57B
- P/E (TTM)
- 20.67
- Forward P/E
- 11.95
- EPS (TTM)
- $1.39
- Shares outstanding
- 89.51M
Price and trading
- Previous close
- 26.68
- Open
- 26.34
- Day range
- 26.34 – 29.35
- 52-week range
- 21.94 – 93.61
- 52-week change
- +11.03%
- Beta
- —
- Volume
- 1.66M
- Average volume
- 2.40M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 2.57B
- Pe
- 20.67
- Forward Pe
- 11.95
- Eps
- 1.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 93.61
- Week52 Low
- 21.94
- Avg Volume
- 2.40M
- Shares Outstanding
- 89.51M
- Ma50
- 68.43
- Ma200
- 54.08
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -69.30%
- Pct From52w Low
- 30.97%